德国R-Biopharm 拜发
R-Biopharm 公司是临床诊断和食品及饲料分析领域的领军企业。在这两个领域中，R-Biopharm 公司的试剂盒能够在危及病人和消费者健康时提供高精确度和准确性的诊断结果。

公司成立于 1988 年，隶属于德国达姆施塔特的Röhm GmbH集团，现任总经理Ralf M.Dreher 博士于 1991 年开始接手公司。自 1996 年以来，R-Biopharm公司的质量管理系统已获 ISO9001 国际标准认证，2003年公司再获 ISO 13485 质量管理证书。从 2000 年 1 月份起，R-Biopharm 公司获得Enzymatic BioAnalysis(酶法生物分析) 试剂的全球独家经销权，该试剂由罗氏公司 (前曼海姆 BOEHRINGER公司) 研发。 　　

2002年 R-Biopharm公司收购了苏格兰的 Rhone诊断技术公司――该公司是另一大霉菌毒素试剂盒生产商。这次在食品和饲料分析领域的成功扩张也最终缔造了R-Biopharm公司在该领域的现有地位。

今天总部位于德国的R-Biopharm公司已经在英国、美国、意大利、法国、阿根廷、巴西、中国、西班牙和澳大利亚成立了子公司，并且建立了全球范围内超过 80 家分销商加盟的巨大销售网，此外，在瑞士、奥地利和荷兰也设有代表处。

R-Biopharm 公司在临床诊断领域，尤其是在传染病粪便诊断学、传染病血清诊断学和过敏诊断学方面有着非常丰富的经验。 2006 年，公司创新的脚步进一步扩展到肿瘤诊断学和肠胃病学产品上。 R-Biopharm已成为一个成功的全球市场舵手，并且在不同领域的检测系统中持续发展和创新。一直以来，产品自动化作为公司的核心，其所有产品均经多方验证且获得 CE 标志。

R-Biopharm在食品和饲料分析领域，公司提供广泛的并经过认证的免疫学、酶学及微生物学试剂盒，用以检测违禁残留物、食品成份以及微生物污染物。采用 R-Biopharm 公司的试剂盒对霉菌毒素、激素、抗生素、转基因物质、风险物质、过敏原和病原体进行检测，具有性价比高、快速、可靠等特点。

在以上两个领域，产品的设计和发展主要采用酶联免疫分析方法，同时也注重 PCR、免疫层析、免疫印记、免疫荧光及快速检测卡等方法。 R-Biopharm 公司拥有的 RIDASCREEN®，RIDA® 和 PentoCheck® 已成为全球著名的商标。

R-Biopharm 公司在业界已赢得很高声誉。公司被连续提名为 2004，2005 及 2006 年度 " 德国年度最佳企业 " ，同时也在 2004 和 2005 年两次被授予德国 " 50 家发展最快的科技公司 "。

R-Biopharm 公司精诚的合作体系以及优良的团队精神得到了客户及科研伙伴的一致认同。公司将始终以全面化和专业化作为其服务理念。

展望未来，R-Biopharm 公司仍将在临床诊断和食品饲料分析领域做出更大的贡献。未来的挑战是开发全新及多功能的快速检测产品以简化流程，缩短时间，获得准确结果。

R-Biopharm AG was founded in 1988 as a subsidiary of Röhm GmbH in Darmstadt, Germany. In 1991 it was taken over by the present managing director, Dr. Ralf M. Dreher. Since 1996 R-Biopharm's quality management systems have been certified to the international standards ISO 9001 and in 2003 the company gained ISO 13485 quality management certification. From January 2000 R-Biopharm acquired sole worldwide distribution rights to Enzymatic BioAnalysis, a product developed by Roche (formerly BOEHRINGER Mannheim). In 2002 R-Biopharm took over Rhône Diagnostics Technologies in Scotland, another supplier of mycotoxin test kits, resulting in successful expansion of its position in the food and feed analysis sector. Today the German parent company R-Biopharm is represented by subsidiaries in the UK, USA, Italy, France, Latin America, Brasil, Spain and China as well as by a worldwide extensive network of more than 80 distributors. In addition, Switzerland, Austria and the Netherlands are represented by local Country Managers.

In clinical diagnostics R-Biopharm possesses many years of sound experience, particularly in the field of infectological stool diagnostics as well as in the field of serological infection diagnostics and allergy diagnostics. 2006 the clinical product portfolio was extended by inovative test systems in the product lines tumor diagnostics and gastroenterology. R-Biopharm has been a successful market player world-wide and is constantly developing new and partly groundbreaking test systems in the different areas. In this process automation is a main focus from the beginning. All distributed tests are validated and CE-marked. In the field of food & feed analysis, the company offers a consistently impressive range of approved immunological, enzymatic and microbiological test kits for the detection of residues, food constituents and microbiological contaminants. The use of R-Biopharm tests to screen for mycotoxins, hormones, antibiotics, genetically modified material, specified risk material, allergens and pathogens is fast, reliable and, above all, cost-effective.

In both fields, the products have been designed and developed primarily for immunoassay platforms. Nonetheless, there is also a great emphasis on other test formats such as PCR, Lateral Flow, Immunoblots, Immunofluorescence Assays or Card Tests. RIDASCREEN®, RIDA® and PentoCheck® were world-wide recognized trademarks of R-Biopharm.

R-Biopharm has earned high accolades for its business performance. In 2004 the company achieved a double success, being nominated as a finalist for 'Entrepreneur of the Year 2004, 2005 and 2006' as well as being placed in 2004 and 2005 in the 'Technology Fast 50', a ranking of Germany's 50 fastest-growing technology companies.

R-Biopharm’s distinctive policy of partnership and teamwork is an approach valued by its customers and research partners alike. The company's key objective is to be a dependable point of contact for customers, providing competent advice on every sector it serves.

At R-Biopharm the future looks set to offer further exciting prospects in the fields of clinical diagnostics and food and feed analysis. The foremost challenge is to advance the development of new and versatile fast tests. These will shorten the time it takes to obtain results from a wide range of analytical procedures.